US FDA Issues Warning Letter To Kilitch Healthcare For Navi-Mumbai Plant

NDTV Profit

US FDA Issues Warning Letter To Kilitch Healthcare For Navi-Mumbai Plant

The US health regulator has pulled up Kilitch Healthcare India for manufacturing lapses, including packing drugs in insanitary conditions at its Maharashtra-based plant. In a warning letter to the company's Managing Director Paresh Mehta, the US Food and Drug Administration pointed out various lapses at the Navi-Mumbai plant, which produces finished pharmaceuticals.The warning letter summarises significant violations of current good manufacturin…